UC San Diego researchers describe how the microbiomes of people and the homes they live in interact and change each other.
UC San Diego study shows suicide rates were higher in pharmacists than in the general population between 2003 and 2018, with job problems being the most significant feature associated with the suicides.
Within the University of California system, the student population of 294,000 is an expanding kaleidoscope of experiences and backgrounds: nearly 40 percent are first-generation university students… 34 percent come from low-income backgrounds… 27 percent are racial and ethnic minorities.
Years of toil in the laboratory have revealed how a marine bacterium makes a potent anti-cancer molecule. Researchers at UC San Diego’s Scripps Institution of Oceanography found that an enzyme called SalC assembles what the team calls the salinosporamide anti-cancer “warhead.”
UC San Diego Health has become the first organization recognized as a Certified Center of Excellence in Medication-Use Safety and Pharmacy Practice by the American Society of Health-System Pharmacists.
Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution.
Six researchers and leaders at the University of California San Diego have been named Fellows of the American Association for the Advancement of Science (AAAS), the largest general science organization in the world and publisher of the journal Science.
National Institutes of Health establishes Microbiome and Metagenomics Center at UC San Diego, part of new effort to predict individual responses to food and inform personalized nutrition recommendations.
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego discover that Botox injections may reduce anxiety.
Leaders in cell biology and anti-malarial drug development respectively, JoAnn Trejo and Elizabeth Winzeler were recognized by their peers with one of the highest honors in health and medicine.